33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral neuropathy in MGUS and progression to amyloid light-chain amyloidosis: A population-based study including 15,351 MGUS cases
    Meeting Abstract

    Rognvaldsson, S.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Blood (2019)

    Fulltext@MSK | Save
  • Belinostat induces high overall response rate (ORR) in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma (AITL)
    Meeting Abstract

    Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S. M.; O'Connor, O. A.
    Blood (2019)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation (alloHSCT) for chronic lymphocytic leukemia (CLL) in the era of novel agents
    Meeting Abstract

    Roeker, L. E.; Brown, J. R.; Dreger, P.; Lahoud, O. B.; Eyre, T. A.; Brander, D. M.; Skarbnik, A.; Coombs, C. C.; Kim, H. T.; Manchini, S. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H. J.; Rosenbaum, C. A.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Timing for allogeneic hematopoietic stem cell transplantation (HSCT) in chronic myelomonocytic leukemia (CMML): A joint study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT
    Meeting Abstract

    Robin, M.; de Wreede, L. C.; Padron, E.; Wang, J.; Hazelaar, S.; Beelen, D. W.; Fenaux, P.; Bornhàˆuser, M.; Kroeger, N.; Nazha, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A randomized trial of EPOCH-based chemotherapy with vorinostat for highly aggressive HIV-associated lymphomas: Updated results evaluating impact of diagnosis-to-treatment interval (DTI) and pre-protocol systemic therapy on outcomes
    Meeting Abstract

    Ramos, J. C.; Sparano, J.; Moore, P. C.; Siegel, E.; Lee, J. Y.; Reid, E. G.; Ambinder, R. F.; Chadburn, A.; Rubinstein, P. G.; Durand, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma
    Meeting Abstract

    Ramos, J. C.; Ambinder, R. F.; Sparano, J.; Lee, J. Y.; Kaplan, L. D.; Wachsman, W.; Aboulafia, D. M.; Noy, A.; Ratner, L.; Henry, D. H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: A phase II study
    Meeting Abstract

    Rampal, R. K.; Verstovsek, S.; Devlin, S. M.; King, A. C.; Stein, E. M.; Pemmaraju, N.; Mauro, M. J.; Kadia, T. M.; Montalban-Bravo, G.; Alvarez, K.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A multicenter retrospective analysis of clinical outcomes, toxicities, and patterns of use in institutions utilizing commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas
    Meeting Abstract

    Riedell, P. A.; Walling, C.; Nastoupil, L. J.; Pennisi, M.; Maziarz, R. T.; McGuirk, J. P.; Oluwole, O. O.; Bachanova, V.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term outcomes of subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disorder (EBV+PTLD) following solid organ (SOT) or allogeneic hematopoietic cell transplants (HCT) treated with tabelecleucel on an expanded access program
    Meeting Abstract

    Prockop, S.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Weng, W. K.; Van Besien, K.; Loeb, D.; Nasta, S. D.; more...
    Blood (2019)

    Fulltext@MSK | Save